Regenerative Protein Array "Cell Factors"

$3,450.00

Groundbreaking advancement in the field of regenerative medicine. RPA (Regenerative Protein Array) is a sophisticated array of proteins, growth factors, and cytokines derived from placental tissue.

This innovative approach is based on the understanding that the therapeutic power of regenerative medicine lies not in the direct transformation of injected stem cells into target tissues, but rather in their ability to modify the surrounding cellular environment through key biological messages.

Regulatory Profile

RPA contains no live cells, only proteins, is a lyophilized and shelf stable product that the FDA classifies as proteins and has no governance over such proteins at this time.


Quantity:
Add To Cart

Groundbreaking advancement in the field of regenerative medicine. RPA (Regenerative Protein Array) is a sophisticated array of proteins, growth factors, and cytokines derived from placental tissue.

This innovative approach is based on the understanding that the therapeutic power of regenerative medicine lies not in the direct transformation of injected stem cells into target tissues, but rather in their ability to modify the surrounding cellular environment through key biological messages.

Regulatory Profile

RPA contains no live cells, only proteins, is a lyophilized and shelf stable product that the FDA classifies as proteins and has no governance over such proteins at this time.


Groundbreaking advancement in the field of regenerative medicine. RPA (Regenerative Protein Array) is a sophisticated array of proteins, growth factors, and cytokines derived from placental tissue.

This innovative approach is based on the understanding that the therapeutic power of regenerative medicine lies not in the direct transformation of injected stem cells into target tissues, but rather in their ability to modify the surrounding cellular environment through key biological messages.

Regulatory Profile

RPA contains no live cells, only proteins, is a lyophilized and shelf stable product that the FDA classifies as proteins and has no governance over such proteins at this time.